Skip to main content

Substance Use

  • Chapter
  • First Online:
Adolescent Pregnancy and Parenting
  • 94 Accesses

Abstract

Substance use disorders disproportionally affect adolescents and young adults, and are especially concerning among pregnant adolescents. Teens who have substance abuse disorders are at increased risk for pregnancy, and although many stop or reduce their use when they learn they are pregnant, many also struggle with dependence or addiction. This chapter focuses on the more common substances of misuse—alcohol, cannabis, opioids, stimulants, hallucinogens, inhalants, and smoking. All have the potential to affect fetal and child development. Pregnancy offers opportunities to intervene as most pregnant women are motivated engage in treatment for the sake of their babies. Substance use disorders are treatable diseases that can be managed successfully by combining medications with behavioral therapy and recovery support.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    “Marginalization” refers to exclusion from social, economic, and/or educational opportunities (owing to economic inequality, violence, stigma, racism, migration), family factors (including neglect and abuse), and individual factors (e.g., disability, ethnicity; [5]).

References

  1. Abel EL. An update on incidence of FAS: FAS is not an equal opportunity birth defect. Neurotoxicol Teratol. 1995;17(4):437–43. https://doi.org/10.1016/0892-0362(95)00005-c.

    Article  CAS  Google Scholar 

  2. Ahmadi-Montecalvo H, Haile ZT, Umer A, Chertok IRA. Adolescent pregnancy and smoking in West Virginia: pregnancy risk assessment monitoring system (PRAMS) 2005–2010. Matern Child Health J. 2016;20(12):2465–73. https://doi.org/10.1007/s10995-016-2040-y.

    Article  Google Scholar 

  3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5TM, 5th ed. (2013-14907-000). American Psychiatric Publishing Inc; 2013. https://doi.org/10.1176/appi.books.9780890425596.

    Book  Google Scholar 

  4. Asante KO, Nelms-Matzke J. Survey of children with chronic handicaps and fetal alcohol syndrome in the Yukon and Northwest BC. Ottawa: Department of Welfare; 1985.

    Google Scholar 

  5. Auerswald CL, Piatt AA, Mirzazadeh A. Research with disadvantaged, vulnerable and/or marginalized adolescents. In: Innocenti Research Briefs 2017- 06, Methods: Conducting Research with Adolescents in Low- and Middle-Income Countries, no. 4. Innocenti: UNICEF Office of Research; 2017.

    Google Scholar 

  6. Barbosa-Leiker C, Burduli E, Smith C, Brooks O, Orr M, Gartstein M. Daily cannabis use during pregnancy and postpartum in a state with legalized recreational cannabis. J Addict Med. 2020;14:101306759. https://doi.org/10.1097/ADM.0000000000000625.

    Article  Google Scholar 

  7. Benowitz NL. Nicotine addiction. N Engl J Med. 2010;362(24):2295–303. https://doi.org/10.1056/NEJMra0809890.

    Article  CAS  Google Scholar 

  8. Bingol N, Schuster C, Fuchs M, Iosub S, Turner G, Stone RK, Gromisch DS. The influence of socioeconomic factors on the occurrence of fetal alcohol syndrome. Adv Alcohol Subst Abuse. 1987;6(4):105–18. https://doi.org/10.1300/J251v06n04_08.

    Article  CAS  Google Scholar 

  9. Black AY, Fleming NA, Rome ES. Pregnancy in adolescents. Adolesc Med State Art Rev. 2012;23(1):38, xi.

    Google Scholar 

  10. Bottorff JL, Poole N, Kelly MT, Greaves L, Marcellus L, Jung M. Tobacco and alcohol use in the context of adolescent pregnancy and postpartum: a scoping review of the literature. Health Soc Care Community. 2014;22(6):561–74. https://doi.org/10.1111/hsc.12091.

    Article  Google Scholar 

  11. Bowen SE. Two serious and challenging medical complications associated with volatile substance misuse: sudden sniffing death and fetal solvent syndrome. Subst Use Misuse. 2011;46(Suppl 1):68–72. https://doi.org/10.3109/10826084.2011.580220.

    Article  Google Scholar 

  12. Carey KB, Guthrie KM, Rich CM, Krieger NH, Norris AL, Kaplan C, Carey MP. Alcohol use and sexual risk behavior in young women: a qualitative study. AIDS Behav. 2019;23(6):1647–55. https://doi.org/10.1007/s10461-018-2310-3.

    Article  Google Scholar 

  13. Centers for Disease Control and Prevention. Annual surveillance report of drug-related risks and outcomes—United States, Surveillance Special Report. Atanta: Centers for Disease Control and Prevention; 2018.

    Google Scholar 

  14. Chamberlain C, O’Mara-Eves A, Porter J, Coleman T, Perlen SM, Thomas J, McKenzie JE. Psychosocial interventions for supporting women to stop smoking in pregnancy. Cochrane Database Syst Rev. 2017;2(2):CD001055. https://doi.org/10.1002/14651858.CD001055.pub5.

    Article  Google Scholar 

  15. Chan B, Freeman M, Kondo K, Ayers C, Montgomery J, Paynter R, Kansagara D. Pharmacotherapy for methamphetamine/amphetamine use disorder-a systematic review and meta-analysis. Addiction. 2019;114(12):2122–36. https://doi.org/10.1111/add.14755.

    Article  Google Scholar 

  16. Charlotte W, Loshak H, Dulong C. Withdrawal management and treatment of crystal methamphetamine addiction in pregnancy: a review of clinical effectiveness and guidelines. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2019. Retrieved from: https://www.ncbi.nlm.nih.gov/books/NBK546255/

    Google Scholar 

  17. Claire R, Chamberlain C, Davey M-A, Cooper SE, Berlin I, Leonardi-Bee J, Coleman T. Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev. 2020;3(3):CD010078. https://doi.org/10.1002/14651858.CD010078.pub3.

    Article  Google Scholar 

  18. Coleman-Cowger VH, Oga EA, Peters EN, Trocin KE, Koszowski B, Mark K. Accuracy of three screening tools for prenatal substance use. Obstet Gynecol. 2019;133(5):952–61. https://doi.org/10.1097/AOG.0000000000003230.

    Article  Google Scholar 

  19. Committee Opinion No. 633: Alcohol abuse and other substance use disorders: ethical issues in obstetric and gynecologic practice. Obstet Gynecol. 2015;125(6):1529–37. https://doi.org/10.1097/01.AOG.0000466371.86393.9b

  20. Committee Opinion No. 722: Marijuana use during pregnancy and lactation. Obstet Gynecol. 2017;130(4):e205–9. https://doi.org/10.1097/AOG.0000000000002354

  21. Constantine NA, Slater JK, Carroll JA, Antin TMJ. Smoking cessation, maintenance, and relapse experiences among pregnant and postpartum adolescents: a qualitative analysis. J Adolesc Health. 2014;55(2):216–21. https://doi.org/10.1016/j.jadohealth.2013.12.027.

    Article  Google Scholar 

  22. Cornelius MD, Day NL. Developmental consequences of prenatal tobacco exposure. Curr Opin Neurol. 2009;22(2):121–5. https://doi.org/10.1097/WCO.0b013e328326f6dc.

    Article  CAS  Google Scholar 

  23. Cornelius MD, Goldschmidt L, DeGenna N, Day NL. Smoking during teenage pregnancies: Effects on behavioral problems in offspring. Nicotine Tob Res. 2007;9(7):739–50. https://doi.org/10.1080/14622200701416971.

    Article  Google Scholar 

  24. Dodge P, Nadolski K, Kopkau H, Zablocki V, Forrestal K, Bailey BA. The impact of timing of in utero marijuana exposure on fetal growth. Front Pediatr. 2023;11:1103749. https://doi.org/10.3389/fped.2023.1103749. PMID: 37260795; PMCID: PMC10228645.

    Article  Google Scholar 

  25. Doherty E, Wiggers J, Wolfenden L, Anderson AE, Crooks K, Tsang TW, Kingsland M. Antenatal care for alcohol consumption during pregnancy: pregnant women’s reported receipt of care and associated characteristics. BMC Pregnancy Childbirth. 2019;19(1):299. https://doi.org/10.1186/s12884-019-2436-y.

    Article  Google Scholar 

  26. Dyba J, Moesgen D, Klein M, Leyendecker B. Methamphetamine use in German Families: parental substance use, parent-child interaction and risks for children involved. Subst Use Misuse. 2019;54(4):583–91. https://doi.org/10.1080/10826084.2018.1528459.

    Article  Google Scholar 

  27. Ecker J, Abuhamad A, Hill W, Bailit J, Bateman BT, Berghella V, Yonkers KA. Substance use disorders in pregnancy: clinical, ethical, and research imperatives of the opioid epidemic: a report of a joint workshop of the Society for Maternal-Fetal Medicine, American College of Obstetricians and Gynecologists, and American Society of Addiction Medicine. Am J Obstet Gynecol. 2019;221(1):B5–B28. https://doi.org/10.1016/j.ajog.2019.03.022.

    Article  Google Scholar 

  28. Elliott TE, Frail CK, Pawloski PA, Thomas AJ, Werner AM, Rossom RC. Opioid use during pregnancy, observations of opioid use, and secular trend from 2006 to 2014 at HealthPartners Medical Group. Clin J Pain. 2018;34(8):707–12.

    Article  Google Scholar 

  29. Embry D, Hankins M, Biglan A, Boles S. Behavioral and social correlates of methamphetamine use in a population-based sample of early and later adolescents. Addict Behav. 2009;34(4):343–51. https://doi.org/10.1016/j.addbeh.2008.11.019.

    Article  Google Scholar 

  30. Fanshawe TR, Halliwell W, Lindson N, Aveyard P, Livingstone-Banks J, Hartmann-Boyce J. Tobacco cessation interventions for young people. Cochrane Database Syst Rev. 2017;11(11):CD003289. https://doi.org/10.1002/14651858.CD003289.pub6.

    Article  Google Scholar 

  31. Fleming N, O’Driscoll T, Becker G, Spitzer RF. Adolescent pregnancy guidelines. J Obstet Gynaecol Can. 2015;37(8):740–56. https://doi.org/10.1016/S1701-2163(15)30180-8.

    Article  Google Scholar 

  32. Forest JS. Hallucinogen use. Medscape; 2020. https://emedicine.medscape.com/article/293752-overview

  33. Gentzke AS, Creamer M, Cullen KA, Ambrose BK, Willis G, Jamal A, King BA. Vital signs: tobacco product use among middle and high school students—United States, 2011-2018. MMWR Morb Mortal Wkly Rep. 2019;68(6):157–64. https://doi.org/10.15585/mmwr.mm6806e1.

    Article  Google Scholar 

  34. Gentzke AS, Wang TW, Jamal A, Park-Lee E, Ren C, Cullen KA, Neff L. Tobacco product use among middle and high school students—United States, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(50):1881–8. https://doi.org/10.15585/mmwr.mm6950a1.

    Article  Google Scholar 

  35. Gray KM. New developments in understanding and treating adolescent marijuana dependence. Adolesc Psychiatry. 2013;3(4):297–306. https://doi.org/10.2174/221067660304140121173215.

    Article  Google Scholar 

  36. Gunn JKL, Rosales CB, Center KE, Nuñez A, Gibson SJ, Christ C, Ehiri JE. Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis. BMJ Open. 2016;6(4):e009986. https://doi.org/10.1136/bmjopen-2015-009986.

    Article  CAS  Google Scholar 

  37. Haden M, Woods B. LSD overdoses: three case reports. J Stud Alcohol Drugs. 2020;81(1):115–8.

    Article  Google Scholar 

  38. Hamel C, Corace K, Hersi M, Rice D, Willows M, Macpherson P, Sproule B, Flores-Aranda J, Garber G, Esmaeilisaraji L, Skidmore B, Porath A, Ortiz Nunez R, Hutton B. Psychosocial and pharmacologic interventions for methamphetamine addiction: protocol for a scoping review of the literature. Syst Rev. 2020;9(1):245. https://doi.org/10.1186/s13643-020-01499-z.

    Article  CAS  Google Scholar 

  39. Harlow AF, Wesselink AK, Hatch EE, Rothman KJ, Wise LA. Male preconception marijuana use and spontaneous abortion: a prospective cohort study. Epidemiology. 2021;32(2):239–47. https://doi.org/10.1097/EDE.0000000000001303. PMID: 33165011; PMCID: PMC7855868.

    Article  Google Scholar 

  40. Hayer S, Mandelbaum AD, Watch L, Ryan KS, Hedges MA, Manuzak JA, Easley CA 4th, Schust DJ, Lo JO. Cannabis and pregnancy: a review. Obstet Gynecol Surv. 2023;78(7):411–28. https://doi.org/10.1097/OGX.0000000000001159. PMID: 37480292; PMCID: PMC10372687.

    Article  Google Scholar 

  41. Hensley L, Sulo S, Kozmic S, Parilla B. Opioid addiction in pregnancy: Does depression negatively impact adherence with prenatal care? J Addict Med. 2018;12:101306759. https://doi.org/10.1097/ADM.0000000000000364.

    Article  Google Scholar 

  42. Huizink AC, Mulder EJH. Maternal smoking, drinking or cannabis use during pregnancy and neurobehavioral and cognitive functioning in human offspring. Neurosci Biobehav Rev. 2006;30(1):24–41. https://doi.org/10.1016/j.neubiorev.2005.04.005.

    Article  CAS  Google Scholar 

  43. Jones KL, Smith DW. Recognition of the fetal alcohol syndrome in early infancy. Lancet. 1973;302(7836):999–1001. https://doi.org/10.1016/s0140-6736(73)91092-1.

    Article  CAS  Google Scholar 

  44. Jones HE, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM, O’Grady KE, Selby P, Martin PR, Fischer G. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med. 2010;363(24):2320–31. https://doi.org/10.1056/NEJMoa1005359.

    Article  CAS  Google Scholar 

  45. Kalaitzopoulos DR, Chatzistergiou K, Amylidi AL, Kokkinidis D, Goulis D, MD, P. Effect of methamphetamine hydrochloride on pregnancy outcome: a systematic review and meta-analysis. J Addict Med. 2018;12(3):220–6. https://doi.org/10.1097/ADM.0000000000000391.

    Article  CAS  Google Scholar 

  46. Kazemi T, Huang S, Avci NG, Waits CMK, Akay YM, Akay M. Investigating the influence of perinatal nicotine and alcohol exposure on the genetic profiles of dopaminergic neurons in the VTA using miRNA-mRNA analysis. Sci Rep. 2020;10(1):15016. https://doi.org/10.1038/s41598-020-71875-1.

    Article  CAS  Google Scholar 

  47. Kharbanda EO, Vazquez-Benitez G, Kunin-Batson A, Nordin JD, Olsen A, Romitti PA. Birth and early developmental screening outcomes associated with cannabis exposure during pregnancy. J Perinatol. 2020;40(3):473–80. https://doi.org/10.1038/s41372-019-0576-6.

    Article  Google Scholar 

  48. Ko JY, Farr SL, Tong VT, Creanga AA, Callaghan WM. Prevalence and patterns of marijuana use among pregnant and nonpregnant women of reproductive age. Am J Obstet Gynecol. 2015;213(2):201.e1–10. https://doi.org/10.1016/j.ajog.2015.03.021.

    Article  Google Scholar 

  49. Kondo KK, Morasco BJ, Nugent SM, Ayers CK, O’Neil ME, Freeman M, Kansagara D. Pharmacotherapy for the treatment of cannabis use disorder: a systematic review. Ann Intern Med. 2020;172(6):398–412. https://doi.org/10.7326/M19-1105.

    Article  Google Scholar 

  50. Kotchick BA, Shaffer A, Forehand R, Miller KS. Adolescent sexual risk behavior: a multi-system perspective. Clin Psychol Rev. 2001;21(4):493–519. https://doi.org/10.1016/s0272-7358(99)00070-7.

    Article  CAS  Google Scholar 

  51. Larcombe AN. Early-life exposure to electronic cigarettes: cause for concern. Lancet Respir Med. 2019;7(11):985–92. https://doi.org/10.1016/S2213-2600(19)30189-4.

    Article  CAS  Google Scholar 

  52. Lowe CR. Effect of mothers’ smoking habits on birth weight of their children. Br Med J. 1959;2(5153):673–6. https://doi.org/10.1136/bmj.2.5153.673.

    Article  CAS  Google Scholar 

  53. May PA, Gossage JP. Maternal risk factors for fetal alcohol spectrum disorders: not as simple as it might seem. Alcohol Res Health. 2011;34(1):15–26.

    Google Scholar 

  54. McGuinness TM, Pollack D. Parental methamphetamine abuse and children. J Pediatr Health Care. 2008;22(3):152–8. https://doi.org/10.1016/j.pedhc.2007.04.009.

    Article  Google Scholar 

  55. McQuire C, Daniel R, Hurt L, Kemp A, Paranjothy S. The causal web of foetal alcohol spectrum disorders: a review and causal diagram. Eur Child Adolesc Psychiatry. 2020;29(5):575–94. https://doi.org/10.1007/s00787-018-1264-3.

    Article  Google Scholar 

  56. Meyer M, Johnston A, Crocker A, Heil S. Methadone and Buprenorphine for Opioid dependence during pregnancy: a retrospective cohort study. J Addict Med. 2015;9(2):81–6. https://doi.org/10.1097/ADM.0000000000000092.

    Article  CAS  Google Scholar 

  57. Miech RA, Schulenberg JE, Johnston LD, Bachman JG, O’Malley PM, Patrick ME. National adolescent drug trends in 2019: findings released. Ann Arbor: Institute for Social Research, The University of Michigan; 2019.

    Google Scholar 

  58. Nagpal TS, Green CR, Cook JL. Vaping during pregnancy: what are the potential health outcomes and perceptions pregnant women have? J Obstet Gynaecol Canada. 2020; https://doi.org/10.1016/j.jogc.2020.05.014.

  59. Natale BV, Gustin KN, Lee K, Holloway AC, Laviolette SR, Natale DRC, Hardy DB. Δ9-tetrahydrocannabinol exposure during rat pregnancy leads to symmetrical fetal growth restriction and labyrinth-specific vascular defects in the placenta. Sci Rep. 2020;10(1):544. https://doi.org/10.1038/s41598-019-57318-6.

    Article  CAS  Google Scholar 

  60. National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. Preventing tobacco use among youth and young adults: a report of the surgeon general. Atlanta (GA): Centers for Disease Control and Prevention (US); 2012. https://www.ncbi.nlm.nih.gov/books/NBK99237/.

  61. National Institute on Alcohol Abuse and Alcoholism. What is binge drinking? Rockville: Author; 2020. Retrieved from https://www.niaaa.nih.gov/publications/brochures-and-fact-sheets/binge-drinking

    Google Scholar 

  62. Nguyen J, O’Brien C, Schapp S. Adolescent inhalant use prevention, assessment, and treatment: a literature synthesis. Int J Drug Policy. 2016;31:15–24. https://doi.org/10.1016/j.drugpo.2016.02.001.

    Article  Google Scholar 

  63. Nichols DE, Grob CS. Is LSD toxic? Forensic Sci Int. 2018;284:141–5. https://doi.org/10.1016/j.forsciint.2018.01.006.

    Article  CAS  Google Scholar 

  64. Paul SE, Hatoum AS, Fine JD, Johnson EC, Hansen I, Karcher NR, Moreau AL, Bondy E, Qu Y, Carter EB, Rogers CE, Agrawal A, Barch DM, Bogdan R. Associations between prenatal cannabis exposure and childhood outcomes: results from the ABCD study. JAMA Psychiatry. 2021;78(1):64–76. https://doi.org/10.1001/jamapsychiatry.2020.2902. PMID: 32965490; PMCID: PMC7512132.

    Article  Google Scholar 

  65. Perez-Reyes M, Wall ME. Presence of delta9-tetrahydrocannabinol in human milk. N Engl J Med. 1982;307(13):819–20. https://doi.org/10.1056/NEJM198209233071311.

    Article  CAS  Google Scholar 

  66. Pesko MF, Currie JM. E-cigarette minimum legal sale age laws and traditional cigarette use among rural pregnant teenagers. J Health Econ. 2019;66:71–90. https://doi.org/10.1016/j.jhealeco.2019.05.003.

    Article  Google Scholar 

  67. Popova S, Lange S, Probst C, Gmel G, Rehm J. Estimation of national, regional, and global prevalence of alcohol use during pregnancy and fetal alcohol syndrome: a systematic review and meta-analysis. Lancet Glob Health. 2017;5(3):e290–9. https://doi.org/10.1016/S2214-109X(17)30021-9.

    Article  Google Scholar 

  68. Poulin C, Graham L. The association between substance use, unplanned sexual intercourse and other sexual behaviours among adolescent students. Addiction. 2001;96(4):607–21. https://doi.org/10.1046/j.1360-0443.2001.9646079.x.

    Article  CAS  Google Scholar 

  69. Prince MK, Ayers D. Substance use in pregnancy. StatPearls. Treasure Island: StatPearls Publishing; 2020. Retrieved from: https://www.ncbi.nlm.nih.gov/books/NBK542330

  70. Roddy E. Bupropion and other non-nicotine pharmacotherapies. BMJ (Clinical Research Ed). 2004;328(7438):509–11. https://doi.org/10.1136/bmj.328.7438.509.

    Article  Google Scholar 

  71. Roncero C, Valriberas-Herrero I, Mezzatesta-Gava M, Villegas JL, Aguilar L, Grau-LĂłpez L. Cannabis use during pregnancy and its relationship with fetal developmental outcomes and psychiatric disorders. A systematic review. Reprod Health. 2020;17(1):25. https://doi.org/10.1186/s12978-020-0880-9.

    Article  Google Scholar 

  72. Salas-Wright CP, Vaughn MG, Ugalde J, Todic J. Substance use and teen pregnancy in the United States: evidence from the NSDUH. Addict Behav. 2015;45:218–25. https://doi.org/10.1016/j.addbeh.2015.01.039.

    Article  Google Scholar 

  73. Shelton KL. Discriminative stimulus effects of abused inhalants. Curr Top Behav Neurosci. 2018;39:113–39.

    Article  CAS  Google Scholar 

  74. Simpson WJ. A preliminary report on cigarette smoking and the incidence of prematurity. Am J Obstet Gynecol. 1957;73(4):807–15.

    Article  CAS  Google Scholar 

  75. Sithisarn T, Granger DT, Bada HS. Consequences of prenatal substance use. Int J Adolesc Med Health. 2012;24(2):105–12. https://doi.org/10.1515/ijamh.2012.016.

    Article  Google Scholar 

  76. Smid MC, Metz TD, Gordon AJ. Stimulant use in pregnancy: an under-recognized epidemic among pregnant women. Clin Obstet Gynecol. 2019;62(1):168–84. https://doi.org/10.1097/GRF.0000000000000418.

    Article  Google Scholar 

  77. Sood B, Delaney-Black V, Covington C, Nordstrom-Klee B, Ager J, Templin T, Janisse J, Martier S, Sokol RJ. Prenatal alcohol exposure and childhood behavior at age 6 to 7 years: I. dose-response effect. Pediatrics. 2001;108(2):E34. https://doi.org/10.1542/peds.108.2.e34.

    Article  CAS  Google Scholar 

  78. Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2018 National Survey on Drug Use and Health, HHS Publication No. PEP19-5068, NSDUH Series H-54. Rockville: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2019. https://www.samhsa.gov/data/

    Google Scholar 

  79. Substance Abuse and Mental Health Services Administration. Treatment of stimulant use disorders, SAMHSA Publication No. PEP20-06-01-001. Rockville: National Mental Health and Substance Use Policy Laboratory; 2020.

    Google Scholar 

  80. Tenenbein M, Casiro OG, Seshia MM, Debooy VD. Neonatal withdrawal from maternal volatile substance abuse. Arch Dis Child Fetal Neonat Educ. 1996;74(3):F204–7.

    Article  CAS  Google Scholar 

  81. Tobon AL, Habecker E, Forray A. Opioid use in pregnancy. Curr Psychiatry Rep. 2019;21(12):118. https://doi.org/10.1007/s11920-019-1110-4.

    Article  Google Scholar 

  82. Towers CV, Katz E, Weitz B, Visconti K. Use of naltrexone in treating opioid use disorder in pregnancy. Am J Obstet Gynecol. 2020;222(1):83.e1–8. https://doi.org/10.1016/j.ajog.2019.07.037.

    Article  CAS  Google Scholar 

  83. Tran DT, Preen DB, Einarsdottir K, Kemp-Casey A, Randall D, Jorm LR, Choi SKY, Havard A. Use of smoking cessation pharmacotherapies during pregnancy is not associated with increased risk of adverse pregnancy outcomes: a population-based cohort study. BMC Med. 2020;18(1):15. https://doi.org/10.1186/s12916-019-1472-9.

    Article  CAS  Google Scholar 

  84. Turner E, Jones M, Vaz LR, Coleman T. Systematic review and meta-analysis to assess the safety of bupropion and varenicline in pregnancy. Nicotine Tob Res. 2019;21(8):1001–10. https://doi.org/10.1093/ntr/nty055.

    Article  CAS  Google Scholar 

  85. US Dept of Health and Human Services, National Institutes of Health. Hallucinogens and dissociative drugs NIDA Research Report Series, NIH Publication Number 15-4209 • Revised February 2015. https://www.drugabuse.gov/sites/default/files/rrhalluc.pdf

  86. Volkow ND, Han B, Compton WM, Blanco C. Marijuana use during stages of pregnancy in the United States. Ann Intern Med. 2017;166(10):763–4. https://doi.org/10.7326/L17-0067.

    Article  Google Scholar 

  87. Warren RJ, Rimoin DL, Sly WS. LSD exposure in utero. Pediatrics. 1970;45(3):466–9.

    Article  CAS  Google Scholar 

  88. Whicher E, Utku F, Schirmer G, Davis P, Abou-Saleh M. Pilot project to evaluate the effectiveness and acceptability of single-session brief counseling for the prevention of substance misuse in pregnant adolescents. Addict Disord Treat. 2012;11:43–9. https://doi.org/10.1097/ADT.0b013e3182387029.

    Article  Google Scholar 

  89. Wolfson L, Schmidt RA, Stinson J, Poole N. Examining barriers to harm reduction and child welfare services for pregnant women and mothers who use substances using a stigma action framework. Health Soc Care Community. 2021; https://doi.org/10.1111/hsc.13335.

  90. World Health Organization. Guidelines for the identification and management of substance use and substance use disorders in pregnancy. Geneva: Author; 2014. Retrieved from https://www.who.int/publications/i/item/9789241548731

    Google Scholar 

  91. Wright TE, Schuetter R, Tellei J, Sauvage L. Methamphetamines and pregnancy outcomes. J Addict Med. 2015;9(2):111–7. https://doi.org/10.1097/ADM.0000000000000101.

    Article  CAS  Google Scholar 

  92. Zapata LB, Hillis SD, Marchbanks PA, Curtis KM, Lowry R. Methamphetamine use is independently associated with recent risky sexual behaviors and adolescent pregnancy. J Sch Health. 2008;78(12):641–8. https://doi.org/10.1111/j.1746-1561.2008.00360.x.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Flaherty, L.T. (2023). Substance Use. In: Wittenberg, JV.P., Becker, D.F., Flaherty, L.T. (eds) Adolescent Pregnancy and Parenting. Springer, Cham. https://doi.org/10.1007/978-3-031-42502-8_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-42502-8_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-42501-1

  • Online ISBN: 978-3-031-42502-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics